4.6 Article

The Geographic Synchrony of Seasonal Influenza: A Waves across Canada and the United States

期刊

PLOS ONE
卷 6, 期 6, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0021471

关键词

-

资金

  1. National FluWatch Network

向作者/读者索取更多资源

Background: As observed during the 2009 pandemic, a novel influenza virus can spread globally before the epidemic peaks locally. As consistencies in the relative timing and direction of spread could form the basis for an early alert system, the objectives of this study were to use the case-based reporting system for laboratory confirmed influenza from the Canadian FluWatch surveillance program to identify the geographic scale at which spatial synchrony exists and then to describe the geographic patterns of influenza A virus across Canada and in relationship to activity in the United States (US). Methodology/Principal Findings: Weekly laboratory confirmations for influenza A were obtained from the Canadian FluWatch and the US FluView surveillance programs from 1997/98 to 2006/07. For the six seasons where at least 80% of the specimens were antigenically similar, we identified the epidemic midpoint of the local/regional/provincial epidemics and analyzed trends in the direction of spread. In three out of the six seasons, the epidemic appeared first in Canada. Regional epidemics were more closely synchronized across the US (3-5 weeks) compared to Canada (5-13 weeks), with a slight gradient in timing from the southwest regions in the US to northeast regions of Canada and the US. Cities, as well as rural areas within provinces, usually peaked within a couple of weeks of each other. The anticipated delay in peak activity between large cities and rural areas was not observed. In some mixed influenza A seasons, lack of synchronization sub-provincially was evident. Conclusions/Significance: As mixing between regions appears to be too weak to force a consistency in the direction and timing of spread, local laboratory-based surveillance is needed to accurately assess the level of influenza activity in the community. In comparison, mixing between urban communities and adjacent rural areas, and between some communities, may be sufficient to force synchronization.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Infectious Diseases

Burden of influenza, respiratory syncytial virus, and other respiratory viruses and the completeness of respiratory viral identification among respiratory inpatients, Canada, 2003-2014

Dena L. Schanzer, Myriam Saboui, Liza Lee, Andrea Nwosu, Christina Bancej

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2018)

Article Biotechnology & Applied Microbiology

Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform

Lisa D. MacDonald, Alecia MacKay, Valarmathy Kaliaperumal, Genevieve Weir, Andrea Penwell, Rajkannan Rajagopalan, Joanne M. Langley, Scott Halperin, Marc Mansour, Marianne M. Stanford

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)

Article Immunology

A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans Study

Joanne M. Langley, Lisa D. MacDonald, Genevieve M. Weir, Donna MacKinnon-Cameron, Lingyun Ye, Shelly McNeil, Bert Schepens, Xavier Saelens, Marianne M. Stanford, Scott A. Halperin

JOURNAL OF INFECTIOUS DISEASES (2018)

Article Immunology

Motivation for participating in phase 1 vaccine trials: Comparison of an influenza and an Ebola randomized controlled trial

A. Cattapan, K. Browne, D. M. Halperin, A. Di Castri, P. Fullsack, J. Graham, J. M. Langley, B. A. Taylor, S. A. McNeil, S. A. Halperin

VACCINE (2019)

Article Pediatrics

The palivizumab patchwork: Variation in guidelines for Respiratory Syncytial Virus prevention across Canadian provinces and territories

Matthew Jalink, Joanne M. Langley

Summary: There is substantial variation in qualifications for RSV prevention with palivizumab among Canadian provinces and territories, and none of them strictly adhere to the guidelines set by the Canadian Paediatric Society. The differences in subnational policies may be due to factors such as resource availability, interpretation of efficacy evidence, epidemiological variations, local pressures, or advocacy efforts.

PAEDIATRICS & CHILD HEALTH (2021)

Article Multidisciplinary Sciences

Birth by Caesarean section and otitis media in childhood: a retrospective cohort study

Maria Hartley, Christy G. Woolcott, Joanne M. Langley, Mary M. Brown, Jillian Ashley-Martin, Stefan Kuhle

SCIENTIFIC REPORTS (2020)

Article Biotechnology & Applied Microbiology

Evaluation of the protective potential of antibody and T cell responses elicited by a novel preventative vaccine towards respiratory syncytial virus small hydrophobic protein

Heather L. Torrey, Valarmathy Kaliaperumal, Yogesh Bramhecha, Genevieve M. Weir, Ann R. Falsey, Edward E. Walsh, Joanne M. Langley, Bert Schepens, Xavier Saelens, Marianne M. Stanford

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)

Article Immunology

A Randomized Controlled Study to Evaluate the Safety and Reactogenicity of a Novel rVLP-Based Plant Virus Nanoparticle Adjuvant Combined with Seasonal Trivalent Influenza Vaccine Following Single Immunization in Healthy Adults 18-50 Years of Age

Joanne Langley, Elodie Pastural, Scott Halperin, Shelly McNeil, May ElSherif, Donna MacKinnon-Cameron, Lingyun Ye, Cecile Grange, Valerie Thibodeau, Jean-Francois Cailhier, Rejean Lapointe, Janet McElhaney, Luis Martin, Marilene Bolduc, Marie-Eve Laliberte-Gagne, Denis Leclerc, Pierre Savard

VACCINES (2020)

Review Immunology

The Power of First Impressions: Can Influenza Imprinting during Infancy Inform Vaccine Design?

Melissa Rioux, Mara McNeil, Magen E. Francis, Nicholas Dawe, Mary Foley, Joanne M. Langley, Alyson A. Kelvin

VACCINES (2020)

Article Public, Environmental & Occupational Health

Mechanical complications of central venous catheters in children: A cohort study

Kieran J. Moore, David Greencorn, Nadine Smith, Joanne M. Langley, Ketan Kulkarni

Summary: This study found that mechanical complications of CVCs are common and significant in the pediatric population, with the highest risk seen in non-tunneled lines. The authors suggest that CVC-associated mechanical complications should be routinely reported as a patient safety outcome.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2022)

Article Pediatrics

Infected branchial cleft cyst in a newborn

Jennifer B. Frazer, Dafydd A. Davies, Joanne M. Langley

Summary: This report presents a case of a newborn with a Staphylococcus aureus infection of a branchial cleft anomaly (BCA) and reviews the characteristics and frequency of infection of this congenital anomaly over 18 years at our center. It is found that 6% of patients presented as neonates and 42% of BCAs became infected.

JOURNAL OF PEDIATRIC SURGERY CASE REPORTS (2022)

Article Biotechnology & Applied Microbiology

Vaccine regulation should require and enforce the inclusion of pregnant and breastfeeding women in prelicensure clinical trials

Terra A. Manca, Manish Sadarangani, Scott A. Halperin, Joanne M. Langley, Elisabeth McClymont, Shannon E. MacDonald, Karina A. Top

Summary: Exclusion of pregnant and breastfeeding women from COVID-19 vaccine trials has led to knowledge gaps, vaccine hesitancy, and misinformation. Inclusion of these populations in trials should be prioritized and regulatory authorities can play a crucial role.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2022)

Article Public, Environmental & Occupational Health

Risk factors for mechanical complications of peripherally inserted central catheters in children

David J. Greencorn, Stefan Kuhle, Lingyun Ye, Kieran J. Moore, Ketan P. Kulkarni, Joanne M. Langley

Summary: Risk factors for mechanical complications in children with PICCs have been identified, which can improve best practices for PICC insertion and care.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2023)

Article Immunology

Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus Vaccine (RSVPreF3) in Mothers and Their Infants: A Phase 2 Randomized Trial

Zourab Bebia, Osvaldo Reyes, Robert Jeanfreau, Anu Kantele, Ruth Graciela De Leon, Marta Garcia Sanchez, Peyman Banooni, Glenn J. Gardener, Jose Luis Bartha Rasero, Maria Begona Encinas Pardilla, Joanne M. Langley, Claudio Maanon Di Leo, Elisabeth Botelho-Nevers, Jim Buttery, Helene Laurichesse, Shabir A. Madhi, Adrian Martin Garcia, Thorsten Stanley, Tiphaine Barjat, Rebecca Griffith, Maria Mercedes Castrejon-Alba, Magali de Heusch, Ilse Dieussaert, Melanie Hercor, Patricia Lese, Hui Qian, Antonella N. Tullio, Ouzama Henry

Summary: Maternal vaccination with RSVPreF3 during late pregnancy has an acceptable safety risk profile and induces robust RSV-specific immune responses with successful antibody transfer to newborns.

JOURNAL OF INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Evaluation of Clinical Case Definitions for Respiratory Syncytial Virus Lower Respiratory Tract Infection in Young Children

Janet A. Englund, Rachel A. Cohen, Veronique Bianco, Joseph B. Domachowske, Joanne M. Langley, Shabir A. Madhi, Khalequ Zaman, Agustin Bueso, Ana Ceballos, Luis Cousin, Sanjay Gandhi, Olivier Gruselle, Lisa Jose, Nicola P. Klein, Anthonet Koen, Thanyawee Puthanakit, Meng Shi, Peter Silas, Auchara Tangsathapornpong, Jamaree Teeratakulpisarn, Timo Vesikari, Gerco Haars, Amanda Leach, Sonia K. Stoszek, Ilse Dieussaert

Summary: Respiratory syncytial virus (RSV) causes respiratory illnesses ranging from common cold to moderate and severe lung disease. Symptoms and methods used to identify/track RSV disease are not always the same in different settings. Three definitions of RSV disease were compared with the World Health Organization (WHO) recommendation in 2015. A universal definition of RSV disease and severity is needed for effective treatment and prevention measures.

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2023)

暂无数据